Trials / Completed
CompletedNCT00235833
Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
Long-term Continuously Repeated Dose Study of Adalimumab (D2E7) in Patients With Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the long-term safety, tolerability, and efficacy of repeated administration of adalimumab in adult Japanese subjects with rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | adalimumab | 40 mg every other week (eow), subcutaneous (sc) |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2004-10-01
- First posted
- 2005-10-12
- Last updated
- 2011-04-11
- Results posted
- 2010-01-29
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00235833. Inclusion in this directory is not an endorsement.